CAMP4 TherapeuticsCAMP
13F holders, Q1 2025 (March 31)39holders +3
7new positions
4sold out
$4.00avg. 13F price*
At the end of Q1 2025, 39 institutions reported holding CAMP4 Therapeutics Corp. (CAMP) in their 13F filings, up 3 from Q4 2024. 7 opened new positions and 4 sold out. The largest holders were Enavate Sciences Gp, LLC ($15.1M), 5AM Venture Management, LLC ($11.7M) and a16z Capital Management, L.L.C. ($8.5M).
- Company
- CAMP4 Therapeutics Corp.
- CUSIP
- 13463J101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $101K |
| Exits | 4 | $1.3M |
All 13F filers, Q4 2024 → Q1 2025: 159,282 shares bought and 335,867 shares sold, net −176,585 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| Enavate Sciences Gp, LLC | 11.41% | No change | 3,785,802 | $15.1M |
| 5AM Venture Management, LLC | 4.43% | No change | 2,927,915 | $11.7M |
| a16z Capital Management, L.L.C. | 1.21% | No change | 2,125,339 | $8.5M |
| HarbourVest Partners LLC | 3.31% | No change | 1,271,948 | $5.1M |
| FMR LLC | 0.00% | Add +1.6% | 766,947 | $3.1M |
| Franklin Resources Inc. | 0.00% | Add +0.0% | 635,054 | $2.5M |
| BlackRock, Inc. | 0.00% | Add +11.6% | 296,216 | $1.2M |
| Vanguard Group Inc. | 0.00% | Add +24.4% | 233,833 | $935K |
| Alyeska Investment Group, L.P. | 0.00% | No change | 200,000 | $800K |
| Geode Capital Management, LLC | 0.00% | Add +10.0% | 159,602 | $638K |
| Victory Capital Management Inc. | 0.00% | Add +31.2% | 81,730 | $327K |
| Northern Trust Corp. | 0.00% | Add +9.8% | 56,939 | $228K |
| State Street Corp. | 0.00% | Add +28.0% | 26,236 | $105K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 16,685 | $67K |
| Bank of New York Mellon Corp | 0.00% | New | 13,118 | $52K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -31.6% | 11,955 | $48K |
| Morgan Stanley | 0.00% | Reduce -37.1% | 8,972 | $36K |
| JPMorgan Chase & Co. | 0.00% | Reduce -61.3% | 8,243 | $33K |
| Barclays PLC | 0.00% | Reduce -29.6% | 7,508 | $30K |
| New York State Common Retirement Fund | 0.00% | New | 6,600 | $26K |
| Rhumbline Advisers | 0.00% | Reduce -88.3% | 5,820 | $23K |
| Citigroup Inc. | 0.00% | Reduce -7.9% | 5,008 | $20K |
| Deutsche Bank AG | 0.00% | New | 4,643 | $19K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +4.3% | 3,786 | $15K |
| Wells Fargo & Company | 0.00% | Add +5.7% | 3,781 | $15K |
| Corebridge Financial, Inc. | 0.00% | Add +1.9% | 3,487 | $14K |
| Bank of America Corp. | 0.00% | Reduce -80.2% | 3,264 | $13K |
| UBS Group AG | 0.00% | Reduce -69.1% | 3,183 | $13K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 720 | $3K |
| Legal & General Group Plc | 0.00% | No change | 708 | $3K |
| California State Teachers Retirement System | 0.00% | No change | 542 | $2K |
| SVB Wealth LLC | 0.00% | New | 500 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -16.7% | 420 | $2K |
| Amalgamated Bank | 0.00% | No change | 235 | $1K |
| Cwm, LLC | 0.00% | New | 260 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | New | 220 | $880 |
| BNP Paribas Financial Markets | 0.00% | Reduce -60.6% | 212 | $848 |
| Sterling Capital Management LLC | 0.00% | Reduce -36.6% | 71 | $284 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 16 | $64 |
"% of holder's portfolio" is CAMP's weight in each manager's 13F, not the share of CAMP4 Therapeutics Corp. the manager owns.